DGCI

Covishield And Covaxin Get Regular Market Approval For Use In Adult Population

The National Regulator, Drugs Controller General of India (DCGI), has given nod to market authorization of two COVID19 vaccines, Covaxin and Covishield subject to certain conditions, here today. The Subject…

View Post

Plea Filed In Delhi High Court Seeking Stay On Phase II/III Clinical Trial Of Covaxin In 2 to 18 Age Group

A Fresh application was moved in Delhi High Court on Thursday seeking to stay the phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18…

View Post

COVID-19: Covaxin Clinical Trials For Children Begin At AIIMS Patna

Patna’s All India Institute of Medical Sciences (AIIMS) has started the paediatric trials for Covaxin. Covaxin, a Covid-19 vaccine is being manufactured by Bharat Biotech. The company has received the…

View Post

DCGI Gives Emergency Approval Of DRDO-Developed Anti-Covid Oral Drug

Anti-Covid oral drug, a drug to treat Covid-19 patients developed by the DRDO (Defence Research and Development Organisation), has been given emergency approval by the country’s developed by the DRDO…

View Post

Spotlight

DGCI Approves Human Trials For Second Potential COVID-19 Vaccine Candidate

Days after privately held Bharat Biotech got a green signal for human studies for its vaccine candidate, the Drug Controller General of India (DGCI) has given similar approval to Zydus…

View Post

Spotlight

CDSCO Allows Imported Drugs With Residual Shelf Life Of Under 60%

New Delhi: In the wake of prevailing Coronavirus situation, Central Drugs Standard Control Organisation (CDSCO) has allowed import of drugs with less than 60 per cent residual shelf life on…

View Post

Menu

Covishield And Covaxin Get Regular Market Approval For Use In Adult Population

Plea Filed In Delhi High Court Seeking Stay On Phase II/III Clinical Trial Of Covaxin In 2 to 18 Age Group

COVID-19: Covaxin Clinical Trials For Children Begin At AIIMS Patna

DCGI Gives Emergency Approval Of DRDO-Developed Anti-Covid Oral Drug

DGCI Approves Human Trials For Second Potential COVID-19 Vaccine Candidate

CDSCO Allows Imported Drugs With Residual Shelf Life Of Under 60%

Vinod Kambli Admitted To Hospital In Maharshtra, Condition Critical

Diabetes and Inflammation Linked to Accelerated Brain Aging and Higher Dementia Risk: Experts

Heart Muscle Regeneration Observed in Patients with Artificial Hearts, Study Finds

Flesh-Eating Ulcer Cases Surge in Australia: Health Authorities Issue Warning

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial